WHO Grade 2 Glioma
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy (NCT04650204) | Mayo Clinic | 2020-12-04 |
| A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (NCT04166409) | National Cancer Institute (NCI) | 2020-01-31 |
| Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations (NCT03212274) | National Cancer Institute (NCI) | 2019-01-30 |
Track WHO Grade 2 Glioma automatically
Every clearance here is in the API, with alerts when new ones post.